Skip to content

Clinical trials

Completed Phase 2 Weight Gain trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Phase 2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20091
20101
20121
20191
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics2
Aardvark Therapeutics, Inc.1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Guilan University of Medical Sciences1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
The University of Texas Health Science Center, Houston1
University of North Carolina, Chapel Hill1
University of Pittsburgh1
University of Western Ontario, Canada1
Wageningen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain11
Obesity5
Schizophrenia3
Mental Disorders2
Bipolar Disorder1
Bulimia1
Diabetes Mellitus1
Hyperglycemia1
Hyperlipidemias1
Neonatal Abstinence Syndrome1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.